This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Variations of the SIR model for COVID-19 evolution (preprint)
arxiv; 2022.
Preprint
in English
| PREPRINT-ARXIV | ID: ppzbmed-2211.08208v1
ABSTRACT
In this work, we discuss the SIR epidemiological model and different variations of it applied to the propagation of the COVID-19 pandemia; we employ the data of the state of Guanajuato and of Mexico. We present some considerations that can improve the predictions made by those models. We consider a time-dependent infection rate, which we adjust to the data. Starting from a linear regime where the populations are much smaller that the country or state population and the population of susceptible (S) can be approximated in convenient units to S approximately 1, we make fits of the parameters. We also consider the case when the susceptible starts departing from 1, for this case we adjust an effective contagion rate. We also explore the ratio of detected populations and the real ones, obtaining that -for the analyzed case it is of approximately 10%. We estimate the number of deaths by making a fit versus the recovered cases, this fit is in first approximation linear, but other powers can give a good agreement. By predictions to past data, we conclude that adaptations of the SIR model can be of great use in describing pandemia's propagation, specially in limited time periods.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-ARXIV
Main subject:
Parkinson Disease
/
COVID-19
Language:
English
Year:
2022
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS